Theriva Biologics, Inc. Subsidiary or Equity Method Investee, Price-Per-Share (Deprecated 2013-01-31)
Theriva Biologics, Inc. (TOVX) had Subsidiary or Equity Method Investee, Price-Per-Share (Deprecated 2013-01-31) of $5 as of 2009-12-31, per its 10-K filed 2013-04-16.
Discontinued › Notes
us-gaap:SubsidiaryOrEquityMethodInvesteePricePerShare · last filed 2013-04-16
- 2009-12-31: Subsidiary or Equity Method Investee, Price-Per-Share (Deprecated 2013-01-31) $5.00.
| Period end | Subsidiary or Equity Method Investee, Price-Per-Share (Deprecated 2013-01-31) |
|---|---|
| 2009-12-31 | $5.00 10-K · filed 2013-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |